CANOPY GROWTH CORP (WEED.CA) Fundamental Analysis & Valuation

TSX:WEED • CA1380357048

1.46 CAD
+0.03 (+2.1%)
Last: Mar 6, 2026, 07:00 PM

This WEED.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall WEED gets a fundamental rating of 3 out of 10. We evaluated WEED against 34 industry peers in the Pharmaceuticals industry. While WEED seems to be doing ok healthwise, there are quite some concerns on its profitability. WEED is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. WEED.CA Profitability Analysis

1.1 Basic Checks

  • WEED had negative earnings in the past year.
  • WEED had a negative operating cash flow in the past year.
  • In the past 5 years WEED always reported negative net income.
  • In the past 5 years WEED always reported negative operating cash flow.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

  • WEED's Return On Assets of -29.52% is on the low side compared to the rest of the industry. WEED is outperformed by 70.59% of its industry peers.
  • WEED has a Return On Equity of -43.07%. This is comparable to the rest of the industry: WEED outperforms 44.12% of its industry peers.
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • WEED's Gross Margin of 26.56% is in line compared to the rest of the industry. WEED outperforms 41.18% of its industry peers.
  • The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

5

2. WEED.CA Health Analysis

2.1 Basic Checks

  • WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • WEED has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, WEED has less shares outstanding
  • WEED has a better debt/assets ratio than last year.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • WEED has an Altman-Z score of -9.08. This is a bad value and indicates that WEED is not financially healthy and even has some risk of bankruptcy.
  • WEED has a Altman-Z score of -9.08. This is in the lower half of the industry: WEED underperforms 79.41% of its industry peers.
  • WEED has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • WEED has a Debt to Equity ratio (0.32) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -9.08
ROIC/WACCN/A
WACC10.81%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • WEED has a Current Ratio of 5.34. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 5.34, WEED belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
  • WEED has a Quick Ratio of 4.26. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.26, WEED belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.34
Quick Ratio 4.26
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

3

3. WEED.CA Growth Analysis

3.1 Past

  • WEED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.98%, which is quite impressive.
  • WEED shows a small growth in Revenue. In the last year, the Revenue has grown by 0.59%.
  • The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.29% on average over the next years. This is quite good.
  • Based on estimates for the next years, WEED will show a small growth in Revenue. The Revenue will grow by 4.95% on average per year.
EPS Next Y92.11%
EPS Next 2Y40.17%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue Next Year3.35%
Revenue Next 2Y3.76%
Revenue Next 3Y3.7%
Revenue Next 5Y4.95%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

1

4. WEED.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as WEED's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y25.31%

0

5. WEED.CA Dividend Analysis

5.1 Amount

  • No dividends for WEED!.
Industry RankSector Rank
Dividend Yield 0%

WEED.CA Fundamentals: All Metrics, Ratios and Statistics

CANOPY GROWTH CORP

TSX:WEED (3/6/2026, 7:00:00 PM)

1.46

+0.03 (+2.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-06
Earnings (Next)05-28
Inst Owners11.04%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap590.02M
Revenue(TTM)278.39M
Net Income(TTM)-326.58M
Analysts47.69
Price Target2.5 (71.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.18%
Min EPS beat(2)-292.16%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-99.19%
Min EPS beat(4)-292.16%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-136.84%
EPS beat(12)3
Avg EPS beat(12)-180.14%
EPS beat(16)3
Avg EPS beat(16)-182.69%
Revenue beat(2)1
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)2.99%
Revenue beat(4)3
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)7
Avg Revenue beat(12)2.61%
Revenue beat(16)8
Avg Revenue beat(16)-0.76%
PT rev (1m)-27.41%
PT rev (3m)-33.78%
EPS NQ rev (1m)-145%
EPS NQ rev (3m)-145%
EPS NY rev (1m)-47.64%
EPS NY rev (3m)-53.68%
Revenue NQ rev (1m)4.14%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.12
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)-1.88
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.69
BVpS1.88
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.56%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.34%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.34
Quick Ratio 4.26
Altman-Z -9.08
F-Score5
WACC10.81%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
EPS Next Y92.11%
EPS Next 2Y40.17%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%
Revenue Next Year3.35%
Revenue Next 2Y3.76%
Revenue Next 3Y3.7%
Revenue Next 5Y4.95%
EBIT growth 1Y56.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.42%
EBIT Next 3Y29.14%
EBIT Next 5Y18.15%
FCF growth 1Y78.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.31%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 3 / 10 to WEED.CA.


Can you provide the valuation status for CANOPY GROWTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.


How profitable is CANOPY GROWTH CORP (WEED.CA) stock?

CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for WEED stock?

The Earnings per Share (EPS) of CANOPY GROWTH CORP (WEED.CA) is expected to grow by 92.11% in the next year.